PMS56 - COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS TOCILIZUMAB WITHOUT METHOTREXATE IN RHEUMATOID ARTHRITIS TREATMENT

Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1770
https://www.valueinhealthjournal.com/article/S1098-3015(18)35072-1/fulltext
Title : PMS56 - COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS TOCILIZUMAB WITHOUT METHOTREXATE IN RHEUMATOID ARTHRITIS TREATMENT
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35072-1&doi=10.1016/j.jval.2018.09.1770
First page :
Section Title :
Open access? : No
Section Order : 1134
Categories :
Tags :
Regions :
ViH Article Tags :